Key barriers in utilizing advanced T-cell engager strategies on solid tumors.
INTRODUCTION T cell engagers (TCEs) are engineered immune-mobilizing molecules that recruit T cells toward tumor cells. TCEs have demonstrated clinical efficacy in hematologic malignancies and currently showing therapeutic potential in solid tumors through the approvals of tebentafusp and tarlatamab in uveal melanoma a...